Literature DB >> 16620064

The role of actin bundling protein fascin in the progression of ovarian neoplasms.

S Kabukcuoglu1, U Oner, S S Ozalp, K Bildirici, O T Yalcin, E Colak.   

Abstract

PURPOSE OF INVESTIGATION: The aim of the study was to investigate the role of fascin in tumor progression and to investigate the role of fascin on endothelial cell migration and angiogenesis in ovarian neoplasms.
METHODS: In the study, 94 malign epithelial ovarian neoplasms, 13 borderline epithelial ovarian neoplasms, 25 serous and mucinous cystadenomas and four normal ovarian tissues were examined by means of immunohistochemistry, using monoclonal antihuman fascin antibody, clone IM20.
RESULTS: Total stromal fascin score in cases of borderline and malign epithelial ovarian tumors was significantly higher compared to normal ovaries and benign epithelial ovarian tumors (.000, p < 0.001). There was no statistically significant difference in terms of total epithelial fascin scores of samples between groups (.080, p > 0.05). Presence of vascular invasion (.000, p < 0.001), psammomatous calcifications (.001, p = 0.001), and lymphocytic infiltration (.000, p < 0.001) were significantly higher in malign neoplasms. There was no significant difference in terms of mean microvessel count and homogeneous or heterogeneous fascin expression of microvessels between the benign and malign groups (respectively p = .228 and p = .143).
CONCLUSIONS: This study suggests that up-regulation of fascin in tumoral tissue may promote invasion of ovarian carcinoma by cell-matrix adhesion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620064

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

Review 1.  FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.

Authors:  Zhongxun Li; Jiao Shi; Nannan Zhang; Xiwang Zheng; Yukun Jin; Shuxin Wen; Wanglai Hu; Yongyan Wu; Wei Gao
Journal:  J Cancer       Date:  2022-05-09       Impact factor: 4.478

2.  An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findings.

Authors:  Andrea Tinelli; Daniele Vergara; Roberta Martignago; Giuseppe Leo; Maurizio Pisanò; Antonio Malvasi
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

3.  Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.

Authors:  Sae Hyun Park; Ji-Ye Song; Yu-Kyung Kim; Jin Hyung Heo; Haeyoun Kang; Gwangil Kim; Hee Jung An; Tae Hoen Kim
Journal:  Int J Oncol       Date:  2013-12-30       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.